NO20076349L - Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse - Google Patents

Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse

Info

Publication number
NO20076349L
NO20076349L NO20076349A NO20076349A NO20076349L NO 20076349 L NO20076349 L NO 20076349L NO 20076349 A NO20076349 A NO 20076349A NO 20076349 A NO20076349 A NO 20076349A NO 20076349 L NO20076349 L NO 20076349L
Authority
NO
Norway
Prior art keywords
syn
amino
acbc
analogs
carboxylic acid
Prior art date
Application number
NO20076349A
Other languages
English (en)
Norwegian (no)
Inventor
Mark M Goodman
Weiping Yu
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of NO20076349L publication Critical patent/NO20076349L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/84—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/04—Saturated compounds having a carboxyl group bound to a three or four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20076349A 2005-06-23 2007-12-11 Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse NO20076349L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69338505P 2005-06-23 2005-06-23
PCT/US2006/023740 WO2007001958A2 (fr) 2005-06-23 2006-06-19 Synthèse stéréo-sélective d'analogues d'acides aminés pour l'imagerie des tumeurs

Publications (1)

Publication Number Publication Date
NO20076349L true NO20076349L (no) 2008-02-15

Family

ID=37595707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076349A NO20076349L (no) 2005-06-23 2007-12-11 Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse

Country Status (8)

Country Link
US (1) US20060292073A1 (fr)
EP (1) EP1893246A4 (fr)
JP (1) JP5349960B2 (fr)
AU (1) AU2006262425C1 (fr)
CA (1) CA2612187C (fr)
NO (1) NO20076349L (fr)
RU (1) RU2376282C2 (fr)
WO (1) WO2007001958A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007001940A2 (fr) * 2005-06-23 2007-01-04 Emory University Agents pour l'imagerie
EP3354639B1 (fr) * 2005-11-29 2024-02-21 Nihon Medi-Physics Co., Ltd. Composé précurseur de composé organique marqué par un atome d'halogène radioactif
JPWO2008056481A1 (ja) * 2006-11-09 2010-02-25 日本メジフィジックス株式会社 放射性画像診断剤
RU2445120C2 (ru) * 2006-12-21 2012-03-20 Нихон Меди-Физикс Ко., Лтд. Радиоактивный агент для диагностической визуализации
EP3530648B1 (fr) * 2006-12-27 2023-11-08 Nihon Medi-Physics Co., Ltd Procédé de fabrication d'un composé précurseur pour composé organique marqué par un atome d'halogène radioactif
US8343459B2 (en) * 2007-02-13 2013-01-01 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
CN101668756A (zh) 2007-05-04 2010-03-10 百时美施贵宝公司 [6,6]和[6,7]-双环gpr119 g蛋白偶合受体激动剂
PE20090213A1 (es) * 2007-05-04 2009-02-28 Bristol Myers Squibb Co Agonistas del receptor acoplado a la proteina g gpr119 [6,5]-biciclicos
US8003796B2 (en) 2007-07-17 2011-08-23 Bristol-Myers Squibb Company Pyridone GPR119 G protein-coupled receptor agonists
WO2009011261A1 (fr) 2007-07-19 2009-01-22 Tokuyama Corporation Composé ayant un cycle hydantoïne et son procédé de fabrication
RU2476423C2 (ru) * 2007-12-19 2013-02-27 Нихон Меди-Физикс Ко., Лтд. Способ получения радиоактивного, меченного фтором органического соединения
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
EP2271372A4 (fr) * 2008-04-14 2012-12-19 Univ Emory Agent d'imagerie
TW201006821A (en) 2008-07-16 2010-02-16 Bristol Myers Squibb Co Pyridone and pyridazone analogues as GPR119 modulators
CA2767478A1 (fr) 2009-07-11 2011-01-20 Bayer Pharma Aktiengesellschaft Procede de radiomarquage au moyen de groupes cycloalkyle
JPWO2011040574A1 (ja) * 2009-09-30 2013-02-28 国立大学法人京都大学 アゼチジニルメトキシピリジン誘導体の製造方法及びその使用
CA2795732A1 (fr) 2010-04-08 2011-10-13 Bristol-Myers Squibb Company Composes analogues de la pyrimidinylpiperidinyloxypyridinone comme modulateurs du gpr119
EP2392568A1 (fr) 2010-06-04 2011-12-07 Bayer Pharma Aktiengesellschaft Acides aminés hétérocycliques pour imagerie du cancer de la prostate
GB201021530D0 (en) * 2010-12-20 2011-02-02 Ge Healthcare Ltd Purification of precursor compound by crystallisation
EP2675789A1 (fr) * 2011-02-17 2013-12-25 Bayer Intellectual Property GmbH 3-(biphényle-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4,5]dec-3-en-2-ones substituées pour la thérapie et des cétoénols spirocycliques substitués par des halogènes
KR101925162B1 (ko) * 2011-03-11 2018-12-04 바이엘 인텔렉쳐 프로퍼티 게엠베하 시스-알콕시-치환된 스피로시클릭 1-h-피롤리딘-2,4-디온 유도체
WO2013011115A1 (fr) * 2011-07-21 2013-01-24 Ge Healthcare Limited Composés précurseurs et leurs procédés de fabrication
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) * 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
US20160108027A1 (en) 2013-06-03 2016-04-21 Bayer Pharma Aktiengesellschaft Substituted benzoxazoles
UY35592A (es) 2013-06-03 2014-12-31 Bayer Pharma AG Benzoxazoles sustituidos
MX2020010634A (es) * 2018-04-10 2020-10-28 Bayer Ag Metodo para la produccion de cetoenoles ciclicos sustituidos por espirocetal.
CN111574389B (zh) * 2020-05-14 2023-08-18 河北威远生物化工有限公司 1-氨基-4-取代环己基羧酸及其盐的顺式异构体的制备方法
CN114031652B (zh) * 2021-11-04 2023-05-26 北京师范大学 一种含环己烷的葡萄糖衍生物及其应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855208A (en) * 1971-05-24 1974-12-17 Becton Dickinson Co Derivatives of digoxigenin
US4325961A (en) * 1977-06-01 1982-04-20 Merck & Co., Inc. Fluorinated amino acids
US4695588A (en) * 1977-06-01 1987-09-22 Merck & Co., Inc. Fluorinated amino acids
US4743691A (en) * 1977-07-11 1988-05-10 Merrell Dow France Et Cie 2-halomethyl derivatives of 2-amino acids
US4483870A (en) * 1978-07-24 1984-11-20 Merck & Co., Inc. α-Difluoromethyl amino acids and hypertension treating compositions thereof
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4358434A (en) * 1979-12-19 1982-11-09 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4942231A (en) * 1984-05-24 1990-07-17 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
US4760091A (en) * 1985-10-01 1988-07-26 The Dow Chemical Company Method of controlling phytopathogenic fungus
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US5116599A (en) * 1989-07-31 1992-05-26 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri
CA2026377A1 (fr) * 1989-10-03 1991-04-04 John L. Krstenansky Peptides anticoagulants avec marqueur radioactif
US5128118A (en) * 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
US6096874A (en) * 1990-10-01 2000-08-01 Board Of Regents, The University Of Texas System High affinity tamoxifen derivatives
US5310912A (en) * 1992-02-25 1994-05-10 Research Biochemicals Limited Partnership Iodinated neuroprobe for mapping monoamine reuptake sites
US5698179A (en) * 1992-02-25 1997-12-16 Neuro Imaging Technologies, Llc Iodinated neuroprobe for mapping monoamine reuptake sites
US5637759A (en) * 1992-07-30 1997-06-10 The Regents Of The University Of California Metal-ligating amino acid derivatives for MRI and for peptide synthesis
US5493026A (en) * 1993-10-25 1996-02-20 Organix, Inc. Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
US6043271A (en) * 1994-08-03 2000-03-28 Sarawak Medichem Pharmaceuticals, Inc. Method for the preparation of (±)-calanolide A and intermediates thereof
IL117574A0 (en) * 1995-04-03 1996-07-23 Bristol Myers Squibb Co Processes for the preparation of cyclobutanone derivatives
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
AUPO763197A0 (en) * 1997-06-30 1997-07-24 Sigma Pharmaceuticals Pty Ltd Health supplement
WO2000064490A1 (fr) * 1999-04-22 2000-11-02 Emory University Fluoroalcenyl nortropanes
US6843979B2 (en) * 1999-04-26 2005-01-18 Emory University 4-haloethenylphenyl tropane:serotonin transporter imaging agents
EP1212103B1 (fr) * 1999-04-26 2004-11-03 Emory University 4-fluoroalkyl-3-halophenyl nortropanes
US7146209B2 (en) * 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
GB0121439D0 (en) * 2001-09-05 2001-10-24 Univ St Andrews An enzymatic process for the generation of organo-fluorine compounds
GB0206117D0 (en) * 2002-03-15 2002-04-24 Imaging Res Solutions Ltd Use of microfabricated devices
DE60333830D1 (de) * 2002-04-30 2010-09-30 Univ Emory Verbindungen zur abbildung von tumoren
GB0229695D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
US20050197350A1 (en) * 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
AU2004268983A1 (en) * 2003-08-27 2005-03-10 Boehringer Ingelheim International Gmbh Cycloalkylaminoacid compounds, processes for making and uses thereof
AU2006250594B2 (en) * 2005-05-23 2011-06-16 Nihon Medi-Physics Co., Ltd. Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
WO2007001940A2 (fr) * 2005-06-23 2007-01-04 Emory University Agents pour l'imagerie

Also Published As

Publication number Publication date
WO2007001958A2 (fr) 2007-01-04
JP2008546783A (ja) 2008-12-25
CA2612187C (fr) 2013-05-07
AU2006262425C1 (en) 2012-06-21
JP5349960B2 (ja) 2013-11-20
WO2007001958A3 (fr) 2007-05-31
AU2006262425B2 (en) 2011-12-08
RU2376282C2 (ru) 2009-12-20
CA2612187A1 (fr) 2007-01-04
RU2008100844A (ru) 2009-07-27
US20060292073A1 (en) 2006-12-28
AU2006262425A1 (en) 2007-01-04
EP1893246A4 (fr) 2009-05-06
EP1893246A2 (fr) 2008-03-05

Similar Documents

Publication Publication Date Title
NO20076349L (no) Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse
BG108497A (en) Solid-phase nucleophilic fluorination
TW200738271A (en) Methods of making radiolabeled tracers and precursors thereof
IL181529A (en) A method for radiofluorination, a compound containing radioactive fluorine and its use in the preparation of a radioactive drug
US20210040126A1 (en) 68Ga-LABELED NOTA-CHELATED PSMA-TARGETED IMAGING AND THERAPEUTIC AGENTS
NO341638B1 (no) Framgangsmåte for å merke en vektor, nye forbindelser og bruk av disse i fremstilling av et radiofarmasøytikum, samt en radiofarmasøytisk sammensetning
ES2304944T3 (es) Composicion que comprende mx-dtpa y su utilizacion para producir un mx-dtpa radiomarcado.
Akurathi et al. Development and biological evaluation of 99mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers
Ogawa et al. Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers
JP2004529884A5 (fr)
CZ20032597A3 (cs) Analogy kyseliny askorbové pro metaloradiofarmaceutika
WO2007148089A3 (fr) Méthodes de radiomarquage
MX2011010295A (es) Reactivos de radiomarcado y metodos.
DE60312136D1 (de) Radiofluorierungsverfahren
NO20074576L (no) Radiolabeled Gallium Complexes, Methods for Synthesis and Use For Pet Imaging of EGFR Expression in Malignant Tumors
AU2014225381B2 (en) Vinylsulfone-based 18f-labeling compositions and methods and uses thereof
Rana et al. Optimization of a novel peptide ligand targeting human carbonic anhydrase IX
BRPI0409101A (pt) método para produzir um complexo de gálio radiomarcado
US8722014B2 (en) 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof
WO2009025914A3 (fr) Analogues de fluorobenzamide radiomarques, synthese et utilisation de ces analogues dans l'imagerie diagnostique
JP2008513503A5 (fr)
MX340407B (es) Simplificacion de proceso para compuesto precursor.
AU698301B2 (en) Complex compounds for diagnosis of vascular diseases
GB0421987D0 (en) Novel technetium and rhenium complexes
WO2005014479A3 (fr) Procede

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application